Chemotherapy‐related cardiotoxicity: are Australian practitioners missing the point?-Reference-Cited by-同舟云学术

Chemotherapy‐related cardiotoxicity: are Australian practitioners missing the point?

Published:2017-10 Issue:10 Volume:47 Page:1166-1172
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Conyers Rachel¹^ORCID,Costello Ben²,La Gerche Andre²,Tripaydonis Anne³,Burns Charlotte¹,Ludlow Louise⁴,Lange Peter⁵,Ekert Paul¹,Mechinaud Francoise¹,Cheung Michael⁶,Martin Michelle¹,Elliot David⁷

Affiliation:

1. Children's Cancer Centre, The Royal Children's Hospital Murdoch Children's Research Institute Melbourne Victoria Australia

2. The Baker IDI Institute The Alfred Hospital Melbourne Victoria Australia

3. Melbourne Medical School Melbourne University Melbourne Victoria Australia

4. Children's Cancer Centre, Tissue Bank Murdoch Children's Research Institute Melbourne Victoria Australia

5. Department of General Medicine The Royal Melbourne Hospital Melbourne Victoria Australia

6. Cardiology Unit, The Royal Children's Hospital Murdoch Children's Research Institute Melbourne Victoria Australia

7. Cardiac Development Laboratory Murdoch Children's Research Institute Melbourne Victoria Australia

Funder

The Children's Cancer Foundation

MyRoom

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.13481

Reference32 articles.

1. Cardiotoxicity Debated for Anthracyclines and Trastuzumab in Breast Cancer

2. Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age

3. Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy

4. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study

5. High Risk of Symptomatic Cardiac Events in Childhood Cancer Survivors

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardio-Oncology Recommendations for Pediatric Oncology Patients;JACC: Advances;2022-12

2. COVID‐19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non‐malignant haematological conditions: Australian and New Zealand Children’s Haematology/Oncology Group consensus statement;Medical Journal of Australia;2022-03-10

3. The Australia and New Zealand Cardio‐Oncology Registry: evaluation of chemotherapy‐related cardiotoxicity in a national cohort of paediatric cancer patients;Internal Medicine Journal;2021-02

4. Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy;Cardio-Oncology;2020-05-21

5. The Role of Antioxidants in Ameliorating Cyclophosphamide-Induced Cardiotoxicity;Oxidative Medicine and Cellular Longevity;2020-05-11